Efficacy and safety of adalimumab in a 120-week open-label extension study in patients with moderate to severe chronic plaque psoriasis

2007 ◽  
Vol 56 (2) ◽  
pp. AB193
Keyword(s):  
Plaque Psoriasis ◽  
Extension Study ◽  
Efficacy And Safety ◽  
Chronic Plaque Psoriasis ◽  
Open Label ◽  
Open Label Extension

scholarly journals Tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension study

2018 ◽  
Vol 179 (4) ◽  
pp. 853-862 ◽  
Author(s):  
F. Valenzuela ◽  
N.J. Korman ◽  
R. Bissonnette ◽  
N. Bakos ◽  
T.-F. Tsai ◽  
...  
Keyword(s):  
Plaque Psoriasis ◽  
Extension Study ◽  
Chronic Plaque Psoriasis ◽  
Open Label ◽  
Safety And Efficacy ◽  
Open Label Extension

scholarly journals Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study

2022 ◽  
Vol 239 ◽  
pp. 83-91
Author(s):  
Yuriy Filts ◽  
Robert E. Litman ◽  
Javier Martínez ◽  
Lourdes Anta ◽  
Dieter Naber ◽  
...  
Keyword(s):  
Extension Study ◽  
Efficacy And Safety ◽  
Open Label ◽  
Term Efficacy ◽  
Open Label Extension

P150 LONG-TERM EFFICACY AND SAFETY OF LANADELUMAB: FINAL RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY

2020 ◽  
Vol 125 (5) ◽  
pp. S21
Author(s):  
A. Banerji ◽  
J. Hao ◽  
M. Yu ◽  
J. Bernstein ◽  
D. Johnston ◽  
...  
Keyword(s):  
Extension Study ◽  
Efficacy And Safety ◽  
Open Label ◽  
Term Efficacy ◽  
Open Label Extension
Sign in / Sign up

Export Citation Format

Share Document